Biomolecules

Advances and Changing Trends in Gene-Based Treatments

Updated

Abstract

are characterized by their precision in targeting genes to suppress specific protein expressions.

  • These therapies include , , microRNAs, and messenger RNAs.
  • They offer highly targeted actions compared to traditional medicinal approaches.
  • Chemical modifications can enhance their resistance to degradation and reduce immune responses.
  • Limited cellular permeability requires the use of delivery vectors for effective intracellular uptake.
  • Nucleic-acid-based therapies show promising pharmacodynamic profiles for clinical research applications.

Simplified

Full Text

What this is

  • () are a growing field in biomedical science, focusing on targeted gene regulation.
  • These therapies include , , microRNAs, and messenger RNAs.
  • offer precision in treating genetic diseases, tumors, and viral infections, with ongoing advancements in delivery mechanisms.
  • This review summarizes the current state of , their mechanisms, challenges, and future prospects.

Essence

  • () are revolutionizing treatment by directly targeting gene expression. They provide a precise method for managing various diseases, leveraging advancements in chemical modifications and delivery systems to enhance efficacy.

Key takeaways

  • can selectively suppress disease-associated proteins, offering a targeted approach to treatment. Their ability to modify gene expression surpasses traditional therapies, making them a promising option for a wide range of conditions.
  • Chemical modifications improve the stability and effectiveness of nucleic acid drugs. These modifications enhance resistance to degradation and increase binding affinity, which is crucial for their therapeutic success.
  • Delivery mechanisms remain a significant challenge for . Strategies such as lipid nanoparticles and conjugation with targeting ligands are being developed to improve cellular uptake and therapeutic efficacy.

Caveats

  • Despite their potential, face challenges in clinical translation due to regulatory hurdles and safety concerns. Immune activation and cytotoxicity from delivery vehicles are notable issues.
  • Delivery efficiency and potential off-target effects hinder the broader application of these therapies. Ongoing research is needed to optimize delivery systems and minimize adverse effects.

Definitions

  • Nucleic-acid-based therapies (NABTs): Therapies that target and regulate gene expression using DNA or RNA molecules to suppress disease-associated proteins.
  • Antisense oligonucleotides (ASOs): Synthetic strands of nucleic acid designed to bind to specific mRNA sequences, leading to the degradation of target RNA.
  • Small interfering RNAs (siRNAs): Short double-stranded RNA molecules that mediate RNA interference, targeting and degrading specific mRNA sequences.

Simplified

Funding

Competing interests

The authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free